Literature DB >> 16272355

Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.

Nilufer Seth1, Daniel Kaufmann, Timothy Lahey, Eric S Rosenberg, Kai W Wucherpfennig.   

Abstract

Chronic infection with the HIV results in poor HIV-specific CD4 T cell proliferation, but more recent analyses using intracellular cytokine staining demonstrated that IFN-gamma-producing, HIV-specific CD4 T cells can be detected for years in HIV-infected subjects. Because it is not known whether the majority of HIV-specific T cells are lost or become dysfunctional, we examined the kinetics of the T cell response over an extended period of time using a panel of 10 HLA-DR tetramers loaded with HIV p24 peptides. Tetramer+ CD4 T cells were present at a relatively high frequency during acute infection, but the size of these populations substantially contracted following suppression of viral replication. Short-term cessation of antiretroviral therapy resulted in a burst of viral replication and concomitant expansion of tetramer+ CD4 T cells, and these populations again contracted following reinitiation of therapy. The kinetics with which these cell populations contracted were characteristic of effector T cells, a conclusion that was supported by their phenotypic (CCR7-CD45RA-) and functional properties (IFN-gamma+). Continued high-level viremia resulted in the physical loss of the majority of tetramer+ CD4 T cells, and the decline of HIV p24-specific CD4 T cells occurred more rapidly and was more substantial than the reduction of total CD4 T cell numbers. We conclude that the population of HIV p24-specific CD4 T cells is initially responsive to changes in the levels of viral Ags, but that the majority of these cells are lost in a setting of chronic viremia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272355      PMCID: PMC3414417          DOI: 10.4049/jimmunol.175.10.6948

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  The dynamics of CD4+ T-cell depletion in HIV disease.

Authors:  J M McCune
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

Review 2.  Cellular immune responses to HIV.

Authors:  A J McMichael; S L Rowland-Jones
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

3.  Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory.

Authors:  D Homann; L Teyton; M B Oldstone
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

4.  Preferential apoptosis of HIV-1-specific CD4+ T cells.

Authors:  Feng Yun Yue; Colin M Kovacs; Rowena C Dimayuga; Xiao Xiao Jenny Gu; Paul Parks; Rupert Kaul; Mario A Ostrowski
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

5.  Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection.

Authors:  A Oxenius; R M Zinkernagel; H Hengartner
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

6.  High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

Authors:  A C McNeil; W L Shupert; C A Iyasere; C W Hallahan; J A Mican; R T Davey; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

7.  Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection.

Authors:  O Pontesilli; P Carotenuto; S R Kerkhof-Garde; M T Roos; I P Keet; R A Coutinho; J Goudsmit; F Miedema
Journal:  AIDS Res Hum Retroviruses       Date:  1999-07-20       Impact factor: 2.205

8.  HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Authors:  Thomas J Scriba; Hua-Tang Zhang; Helen L Brown; Annette Oxenius; Norbert Tamm; Sarah Fidler; Julie Fox; Jonathan N Weber; Paul Klenerman; Cheryl L Day; Michaela Lucas; Rodney E Phillips
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

9.  Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.

Authors:  U Malhotra; S Holte; S Dutta; M M Berrey; E Delpit; D M Koelle; A Sette; L Corey; M J McElrath
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

10.  Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P Moss; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; A Hurley; M Markowitz; D D Ho; A J McMichael; D F Nixon
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  22 in total

1.  Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.

Authors:  Elizabeth Connick; Ronald J Bosch; Evgenia Aga; Rick Schlichtemeier; Lisa M Demeter; Paul Volberding
Journal:  J Acquir Immune Defic Syndr       Date:  2011-09-01       Impact factor: 3.731

2.  Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques.

Authors:  Alexandra M Ortiz; Nichole R Klatt; Bing Li; Yanjie Yi; Brian Tabb; Xing Pei Hao; Lawrence Sternberg; Benton Lawson; Paul M Carnathan; Elizabeth M Cramer; Jessica C Engram; Dawn M Little; Elena Ryzhova; Francisco Gonzalez-Scarano; Mirko Paiardini; Aftab A Ansari; Sarah Ratcliffe; James G Else; Jason M Brenchley; Ronald G Collman; Jacob D Estes; Cynthia A Derdeyn; Guido Silvestri
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 3.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

4.  Identification of HIV-1-specific regulatory T-cells using HLA class II tetramers.

Authors:  Mathieu Angin; Melanie King; Marcus Altfeld; Bruce D Walker; Kai W Wucherpfennig; Marylyn M Addo
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

Review 5.  Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise.

Authors:  Brandon S Razooky; Leor S Weinberger
Journal:  Methods       Date:  2010-12-16       Impact factor: 3.608

6.  Glycosylation of simian immunodeficiency virus influences immune-tissue targeting during primary infection, leading to immunodeficiency or viral control.

Authors:  Chie Sugimoto; Shinichiro Nakamura; Shoko I Hagen; Yasuko Tsunetsugu-Yokota; Francois Villinger; Aftab A Ansari; Yasuo Suzuki; Naoki Yamamoto; Yoshiyuki Nagai; Louis J Picker; Kazuyasu Mori
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

7.  HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.

Authors:  Benoît Vingert; Santiago Perez-Patrigeon; Patricia Jeannin; Olivier Lambotte; Faroudy Boufassa; Fabrice Lemaître; William W Kwok; Ioannis Theodorou; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

8.  HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Authors:  Benoît Vingert; Daniela Benati; Olivier Lambotte; Pierre de Truchis; Laurence Slama; Patricia Jeannin; Moran Galperin; Santiago Perez-Patrigeon; Faroudy Boufassa; William W Kwok; Fabrice Lemaître; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

Review 9.  T-cell exhaustion in HIV infection.

Authors:  Mohamed El-Far; Rabih Halwani; Elias Said; Lydie Trautmann; Mehrnoosh Doroudchi; Loury Janbazian; Simone Fonseca; Julien van Grevenynghe; Bader Yassine-Diab; Rafick-Pierre Sékaly; Elias K Haddad
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

10.  Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.

Authors:  Jonah B Sacha; Juan P Giraldo-Vela; Matthew B Buechler; Mauricio A Martins; Nicholas J Maness; Chungwon Chung; Lyle T Wallace; Enrique J León; Thomas C Friedrich; Nancy A Wilson; Atsunobu Hiraoka; David I Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.